The new anti-oncogene clusterin and the molecular profiling of prostate cancer progression and prognosis
Acta Biomed. 2003 Aug;74(2):101-4.
[Article in
English,
Italian]
Affiliation
- 1 Dipartimento di Medicina Sperimentale, Sezione di Biochimica, Biochimica Cinica e Biochimica dell'Esercizio Fisico, Università degli Studi di Parma, Via Volturno 39, 43100 Parma, Italy. saverio.bettuzzi@unipr.it
No abstract available
MeSH terms
-
Apoptosis
-
Biomarkers, Tumor
-
Blotting, Northern
-
Blotting, Western
-
Cell Line
-
Clusterin
-
Cohort Studies
-
Down-Regulation
-
Follow-Up Studies
-
Gene Expression
-
Genes, Tumor Suppressor*
-
Glycoproteins* / analysis
-
Glycoproteins* / genetics
-
Glycoproteins* / metabolism
-
Humans
-
Immunohistochemistry
-
Male
-
Molecular Chaperones* / analysis
-
Molecular Chaperones* / genetics
-
Molecular Chaperones* / metabolism
-
Neoplasm Recurrence, Local / genetics
-
Prognosis
-
Prostate-Specific Antigen / blood
-
Prostatic Neoplasms / drug therapy
-
Prostatic Neoplasms / genetics*
-
Prostatic Neoplasms / radiotherapy
-
Research
Substances
-
Biomarkers, Tumor
-
CLU protein, human
-
Clusterin
-
Glycoproteins
-
Molecular Chaperones
-
Prostate-Specific Antigen